Dr. Stephanie Gaillard, MD
Claim this profileJohns Hopkins University/Sidney Kimmel Cancer Center
Studies Ovarian Cancer
Studies Endometrial Cancer
10 reported clinical trials
21 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
MSI positive
dMMR positive
2Endometrial Cancer
PIK3CA positive
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Stephanie Gaillard, MD is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Avutometinib + Defactinib
for Ovarian Cancer
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (ICT) in subjects with recurrent LGSOC who have progressed on a prior platinum-based therapy.
Recruiting2 awards Phase 38 criteria
More about Stephanie Gaillard, MD
Clinical Trial Related2 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Stephanie Gaillard, MD has experience with
- Bevacizumab
- Paclitaxel
- Carboplatin
- Fulvestrant
- Alpelisib
- Fostamatinib
Breakdown of trials Stephanie Gaillard, MD has run
Ovarian Cancer
Endometrial Cancer
Cancer
Fallopian Tube Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephanie Gaillard, MD specialize in?
Stephanie Gaillard, MD focuses on Ovarian Cancer and Endometrial Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are MSI positive.
Is Stephanie Gaillard, MD currently recruiting for clinical trials?
Yes, Stephanie Gaillard, MD is currently recruiting for 6 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Stephanie Gaillard, MD has studied deeply?
Yes, Stephanie Gaillard, MD has studied treatments such as Bevacizumab, Paclitaxel, Carboplatin.
What is the best way to schedule an appointment with Stephanie Gaillard, MD?
Apply for one of the trials that Stephanie Gaillard, MD is conducting.
What is the office address of Stephanie Gaillard, MD?
The office of Stephanie Gaillard, MD is located at: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland 21287 United States. This is the address for their practice at the Johns Hopkins University/Sidney Kimmel Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.